The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-cyclopentyl-6-((1-morpholino-1-oxopropan-2-yl)amino)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one ID: ALA4544864
PubChem CID: 155553114
Max Phase: Preclinical
Molecular Formula: C17H24N6O3
Molecular Weight: 360.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](Nc1nc2c(cnn2C2CCCC2)c(=O)[nH]1)C(=O)N1CCOCC1
Standard InChI: InChI=1S/C17H24N6O3/c1-11(16(25)22-6-8-26-9-7-22)19-17-20-14-13(15(24)21-17)10-18-23(14)12-4-2-3-5-12/h10-12H,2-9H2,1H3,(H2,19,20,21,24)/t11-/m1/s1
Standard InChI Key: GESQMVSOZXARLD-LLVKDONJSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
7.8422 -2.7081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8422 -3.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5550 -3.9398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5550 -2.2892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2637 -2.7081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2681 -3.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0513 -3.7782 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5324 -3.1099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0440 -2.4512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3158 -4.5586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8327 -5.2297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3231 -5.8955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1068 -5.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1022 -4.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1275 -3.9449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4116 -3.5354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6970 -3.9470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4104 -2.7101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9811 -3.5375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6982 -4.7723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5550 -1.4639 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9779 -2.7157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2660 -2.3021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5490 -2.7144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5482 -3.5407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2645 -3.9547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 10 1 0
7 10 1 0
2 15 1 0
15 16 1 0
16 17 1 0
16 18 1 1
17 19 1 0
17 20 2 0
4 21 2 0
19 22 1 0
19 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.42Molecular Weight (Monoisotopic): 360.1910AlogP: 0.89#Rotatable Bonds: 4Polar Surface Area: 105.14Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.56CX Basic pKa: 1.69CX LogP: 0.12CX LogD: 0.11Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.84Np Likeness Score: -1.75
References 1. Wu Y, Zhou Q, Zhang T, Li Z, Chen YP, Zhang P, Yu YF, Geng H, Tian YJ, Zhang C, Wang Y, Chen JW, Chen Y, Luo HB.. (2019) Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia., 62 (8): [PMID:30916555 ] [10.1021/acs.jmedchem.8b01041 ] 2. Wu Y, Wang Q, Jiang MY, Huang YY, Zhu Z, Han C, Tian YJ, Zhang B, Luo HB.. (2021) Discovery of Potent Phosphodiesterase-9 Inhibitors for the Treatment of Hepatic Fibrosis., 64 (13.0): [PMID:34142552 ] [10.1021/acs.jmedchem.1c00862 ]